NALMEFENE HCL
Live / Applied — Fifth extension granted (statement of use) (as of 30 Jan 2026)
What this means for you
Not registered yet, but its 10 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97306650
- Mark type
- Design + words
- Filed
- 10 Mar 2022
- Published for opposition
- 17 Jan 2023
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Owner
- Purdue Pharma L.P., Stamford, CT, US
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 30 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2026 — SOU EXTENSION 5 GRANTED
- 10 Sept 2025 — SOU EXTENSION 5 FILED
- 30 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 4 GRANTED
- 05 Mar 2025 — SOU EXTENSION 4 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 3 GRANTED
- 12 Sept 2024 — SOU EXTENSION 3 FILED
- 12 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 2 GRANTED